Histone Deacetylase Inhibitors: 749 Clinical Trials, Page 2 of 75

«1 2 3 4 5 …10 15 20 … »Last Page »

Hide Studies Not Open or Pending

A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome

Condition(s):Advanced or Refractory Leukemia; Myelodysplastic SyndromesLast Updated:September 14, 2012Terminated

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Condition(s):Peripheral T-cell LymphomaLast Updated:December 6, 2021Recruiting

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Condition(s):Advanced Hematologic MalignanciesLast Updated:April 1, 2015Completed

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Condition(s):Vestibular Schwannoma; Meningioma; Acoustic Neuroma; Neurofibromatosis Type 2Last Updated:May 11, 2022Terminated

Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma

Condition(s):ChordomaLast Updated:December 27, 2012Unknown status

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Condition(s):Non-small Cell Lung Cancer; Epithelial Ovarian CancerLast Updated:May 3, 2016Completed

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Condition(s):HIVLast Updated:January 17, 2018Completed

A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma

Condition(s):Multiple MyelomaLast Updated:January 22, 2020Completed

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Condition(s):Breast CancerLast Updated:March 13, 2017Withdrawn

Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART

Condition(s):HIV InfectionLast Updated:February 25, 2014Completed

«1 2 3 4 5 …10 15 20 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.